Dyne Therapeutics (DYN) Climbs 9.5% on Stellar Results for DMD Therapy Candidate
We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the best performers on Monday. Dyne Therapeutics jumped by 9.47 percent on Monday to finish at $22.20 apiece as investors cheered the encouraging results from its ongoing clinical trial to test the efficacy of therapy candidate, zeleciment rostudirsen, for individuals with Duchenne muscular dystrophy (DMD). In an update on the same day, Dyne Therapeutics, Inc. (NASDAQ:DYN) sa ...